loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of Drug Master Files (JDMF) for Epalrestat Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DNP Fine Chemical Utsunomiya Co., Ltd. (1)

02 EISAI PHARMACEUTICALS INDIA PVT LTD (1)

03 Ouchi Shinko Chemical Industry Co., Ltd. (2)

04 Sanpo Chemical Research Institute Co., Ltd. (1)

05 Sanyo Chemical Research Institute Co., Ltd. (1)

06 Xi'an Wanlong Pharmaceutical Co. ,Ltd (1)

07 Zhejiang East Asia Pharmaceutical Co. , Ltd. (2)

filter

01 Epalrestat (3)

02 Epalrestat (production only) (2)

03 Japanese Pharmacopoeia Epalrestat (2)

04 Japanese Pharmacopoeia Epalrestat (manufacturing only) (1)

05 Japanese Pharmacopoeia Epalrestat (production only) (1)

filter

01 China (3)

02 Gabon (1)

03 Japan (5)

URL Supplier Web Content
218MF10360
1062-8 Honjo, Nishikata-cho, Tochig...
2014-02-05
2006-03-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
229MF10005
Ramky Pharma City (SEZ), Plot Nos. ...
2019-06-05
2017-01-10
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
229MF10117
1-31 Jinnanbecho, Sakai-ku, Sakai-s...
2018-02-26
2017-07-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
217MF10698
7-4 Kobune-cho, Nihonbashi, Chuo-ku...
2008-02-25
2005-10-07
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
301MF10017
7-4 Kobune-cho, Nihonbashi, Chuo-ku...
2019-06-07
2019-06-07
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
303MF10164
NO. 5, Chuangxin Road, New Industri...
2021-11-17
2021-11-17
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Sanyo Chemical Research Institute C...

Contact Supplier
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
224MF10240
148-1 Tajii, Mihara Ward, Sakai Cit...
2012-12-28
2012-12-28
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
230MF10015
23rd Floor, Chamber of Commerce Bui...
2018-01-30
2018-01-30
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
219MF10317
23rd Floor, Chamber of Commerce Bui...
2007-10-24
2007-10-24
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 82159-09-9 / Epalrestat API manufacturers, exporters & distributors?

Epalrestat manufacturers, exporters & distributors 1

77

PharmaCompass offers a list of Epalrestat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Epalrestat manufacturer or Epalrestat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Epalrestat manufacturer or Epalrestat supplier.

PharmaCompass also assists you with knowing the Epalrestat API Price utilized in the formulation of products. Epalrestat API Price is not always fixed or binding as the Epalrestat Price is obtained through a variety of data sources. The Epalrestat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Epalrestat

Synonyms

82159-09-9, Kinedak, Epalrestatum, Epalrestat [inn], Ono 2235, Ono-2235

Cas Number

82159-09-9

Unique Ingredient Identifier (UNII)

424DV0807X

About Epalrestat

Epalrestat is an orally available, a non-competitive, reversible inhibitor of aldose reductase (AR), with potential antineoplastic, antioxidant, and anti-inflammatory activities. Upon oral administration, epalrestat non-competitively binds to AR, a polyol pathway enzyme that catalyzes reactive oxygen species (ROS)-initiated lipid peroxidation-generated lipid aldehydes and their glutathione conjugates, which have been implicated in the activation of transcription factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) and activator protein-1 (AP-1), which control the transcription of many inflammatory cytokines. Increased inflammatory cytokines and growth factors promote cell proliferation, a primary feature in the tumorigenesis process. AR is overexpressed in several oxidative stress- and inflammation-related conditions, including cancer.

Epalrestat Manufacturers

A Epalrestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epalrestat, including repackagers and relabelers. The FDA regulates Epalrestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epalrestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Epalrestat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Epalrestat Suppliers

A Epalrestat supplier is an individual or a company that provides Epalrestat active pharmaceutical ingredient (API) or Epalrestat finished formulations upon request. The Epalrestat suppliers may include Epalrestat API manufacturers, exporters, distributors and traders.

click here to find a list of Epalrestat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Epalrestat JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Epalrestat Drug Master File in Japan (Epalrestat JDMF) empowers Epalrestat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Epalrestat JDMF during the approval evaluation for pharmaceutical products. At the time of Epalrestat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Epalrestat suppliers with JDMF on PharmaCompass.

Epalrestat Manufacturers | Traders | Suppliers

Epalrestat Manufacturers, Traders, Suppliers 1
65

We have 6 companies offering Epalrestat

Get in contact with the supplier of your choice:

  1. DNP Fine Chemicals
  2. Eisai
  3. Hosho Co
  4. OUCHI SHINKO CHEMICAL INDUSTRIAL
  5. Xian Wanlong Pharmaceutical Co. Ltd
  6. Zhejiang East Asia Pharmaceutical
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY